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ABSTRACT
The p110 Cut homeobox 1 (CUX1) transcription
factor regulates genes involved in DNA replication
and chromosome segregation. Using a genome-
wide-approach, we now demonstrate that CUX1
also modulates the constitutive expression of DNA
damage response genes, including ones encoding
ATM and ATR, as well as proteins involved
in DNA damage-induced activation of, and signaling
through, these kinases. Consistently, RNAi
knockdown or genetic inactivation of CUX1
reduced ATM/ATR expression and negatively
impacted hallmark protective responses mediated
by ATM and ATR following exposure to ionizing
radiation (IR) and UV, respectively. Specifically,
abrogation of CUX1 strongly reduced ATM autopho-
sphorylation after IR, in turn causing substantial
decreases in (i) levels of phospho-Chk2 and p53,
(ii) c-H2AX and Rad51 DNA damage foci and
(iii) the efficiency of DNA strand break repair.
Similarly remarkable reductions in ATR-dependent
responses, including phosphorylation of Chk1 and
H2AX, were observed post-UV. Finally, multiple cell
cycle checkpoints and clonogenic survival were
compromised in CUX1 knockdown cells. Our
results indicate that CUX1 regulates a transcrip-
tional program that is necessary to mount an effi-
cient response to mutagenic insult. Thus, CUX1
ensures not only the proper duplication and segre-
gation of the genetic material, but also the preser-
vation of its integrity.
INTRODUCTION
The Cut homeobox gene 1 (CUX1) encodes several tran-
scription factor isoforms with distinct DNA binding and
regulatory properties [(1,2), reviewed in (3)]. One isoform,
p110 CUX1, functions as a transcriptional regulator of cell
cycle progression (4,5). Genetic studies in Drosophila
melanogaster showed that Cut is an important determinant
of cell-type speciﬁcity in several tissues [reviewed in (6)].
Homozygous inactivation of Cux1 in mice causes perinatal
lethality in a large proportion of animals due to delayed
lung development and associated respiratory failure (7).
Surviving mice are usually male and exhibit growth retard-
ation, disrupted hair follicle morphogenesis, purulent
rhinitis, infertility, cachexia and reduction of B and T cell
content in bone marrow and thymus, respectively (7–9).
The basis for some among these multiple phenotypes
appears to involve both cell-autonomous and non-
autonomous processes. In transgenic mouse models,
overexpression of CUX1 generated various cancer-
associated disorders depending on the speciﬁc isoform
and tissue type expression. These include multi-organ
organomegaly, glomerulosclerosis and polycystic kidneys,
pre-cancerous lesions in the liver, myeloproliferative-
disease-like myeloid leukemias and mammary tumors
sometimes associated with lung metastasis (10–14).
Immunohistochemical analysis of human breast and pan-
creatic cancer tissues demonstrated that CUX1 protein
expression was increased in high histological grade
tumors relative to low grade ones (15,16). It has been
proposedthattheparticipation ofCUX1 in tumorprogres-
sion involves its role in cell motility. Consistent with this
notion, siRNA-mediated knockdown of CUX1 caused a
decrease in, whereas overexpression of p110 or p75
CUX1stimulated,bothcellmigrationandinvasion(15,17).
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initiation likely involve roles for this protein in cell cycle
progression [(18–20); reviewed in (3)]. CUX1 expression
and activity are tightly regulated in a cell cycle-dependent
manner, mostly through phosphorylation/dephosphory-
lation by cyclin A/Cdk2, cyclin A/Cdk1 cyclin B/Cdk1
and Cdc25A, as well as through proteolytic processing
by nuclear cathepsin L and a caspase-like protease
(4,21–26). Genome-wide location analysis revealed that
p110 CUX1 binds to the promoter of several genes that
participate in DNA replication and cell cycle progression
from S phase through the end of mitosis (5). In agreement
with these ﬁndings, G1 was prolonged in mouse embryo
ﬁbroblasts derived from Cux1
z/z knockout mice, whereas
constitutive expression of p110 CUX1 accelerated entry
into S phase and stimulated cell proliferation (20). More
recently, CUX1 was shown to up-regulate the expression
of genes that fulﬁll important functions in mitosis and the
spindle assembly checkpoint. Although these activities of
CUX1 in normal cells ensure proper chromosomal segre-
gation, higher CUX1 expression in cancer cells can lead to
chromosomal instability following cytokinesis failure (27).
Of major relevance here, another category of genes
enriched among transcriptional targets of CUX1 is
known to be involved in the processing of DNA
damage. Thus, the aim of the present study was to inves-
tigate a potential role of CUX1 in the cellular response to
mutagenic insult, commonly referred to as the DNA
damage response (DDR), which depends on the activity
of numerous proteins acting as sensors, mediators, signal
transducers and effectors (28). The early DDR is largely
mounted in a DNA lesion-speciﬁc manner. In the case of
DNA double strand breaks (DSBs) generated by
clastogens such as ionizing radiation (IR), the Mre11-
Rad50-NBS1 (MRN) complex (Mre11-Rad50-NBS1)
senses the break and initiates recruitment and activation
(i.e. autophosphorylation) of ATM kinase (29). On the
other hand, helix-distorting adducts, including
UV-induced pyrimidine dimers, strongly block DNA rep-
lication which results in formation of large tracts of
single-stranded DNA (ssDNA) due to functional
uncoupling of DNA synthetic enzymes at stalled replica-
tion forks (30,31). The ensuing avid binding of replication
protein-A (RPA) to ssDNA tracts speciﬁcally activates
ATR kinase by facilitating the association of Ataxia-
Telangiectasia and Rad3-Related – ATR-Interacting
Protein (ATR–ATRIP), TopBP1 and the 911 complex
(Rad9-Rad1-Hus1) (30,32). ATR or ATM then rapidly
phosphorylate hundreds of downstream targets (many in
common) including, very prominently, the transducers
Chk1 or Chk2 respectively, and the p53 and BRCA1
tumor suppressors, which regulate cell cycle checkpoints
and/or DNA repair (33). Following IR exposure, rapid
phosphorylation of H2AX by ATM (to form g-H2AX)
is required for recruitment of the DDR machinery to
DSB sites (34). The biological role of a similarly rapid
ATR-mediated g-H2AX induction in response to
replication-blocking adducts generated by UV is consider-
ably less clear, but may serve a similar purpose (35).
Genome-wide location analysis suggested that p110
CUX1 localizes to the promoters of several genes
involved in the DDR (5). We conﬁrm using independent
chromatin immunoprecipitation assays and expression
studies that p110 CUX1 indeed binds the promoters,
and regulates expression, of DDR genes. Of particular
note, CUX1 is shown to be required for full expression
of the ATM and ATR checkpoint kinases in the absence
of genotoxic stress, as well as of proteins required for ac-
tivation of these kinases after treatment with DNA
damaging agents. Moreover abrogation of CUX1 expres-
sion engenders defects in ATM/ATR-mediated DDR sig-
naling, cell cycle checkpoint control and cell survival
following exposure to either UV or IR. Our data reveal
that the CUX1 transcription factor, in addition to its
critical role in regulating normal cell growth, is also
required for robust ATM-/ATR-mediated cellular re-
sponses to genotoxic stress.
MATERIALS AND METHODS
Cell culture
All cells were maintained in Dulbecco’s modiﬁed minimum
essential medium (DMEM, Wisent) supplemented with
10% Fetal Bovine Serum (Invitrogen) (5% FBS for
Hs578T) and penicillin–streptomycin (Invitrogen). The
Hs578T and MCF7 cells were grown at 37 C, 5% CO2
and atmospheric O2, whereas mouse embryonic ﬁbroblasts
(MEFs) were grown at 37 C, 5% CO2 and 3% O2.
MEF cell isolation
Cux1 mutant mice in the albino OF1 outbred strain were
obtained from the laboratory of Meinrad Busslinger and
were maintained in the OF1 genetic background (7).
Primary MEFs were prepared from 13.5-day-old
embryos, and heads were used for genotyping. Limbs
and internal organs were removed, and the body was
minced and incubated for 10min in trypsin. Cells were
then washed once in complete medium and seeded in a
100-mm dish.
siRNA knockdown
CUX1 knockdown was performed by transfecting cells
with a pair of siRNA constructs speciﬁc for CUX1
mRNA (50 GAAUCUUCUCGUUUGAAACUUUGAA
and 50 GCUUCAGAGCGAUAAUACACUAUUA)
using Lipofectamine2000 (Invitrogen) according to the
manufacturer’s instructions. Knockdown was performed
7 days and again 2 days prior to performing experiments.
In the case of clonogenic survival assays, knockdown was
performed 5 days and again 5h prior to the experiment.
Retroviral infection
Retroviruses were produced by transfecting 293VSV cells
with either the pREV/TRE empty vector (Clontech) or
one encoding p110 CUX1 [CUX1 aa 747–1505, Myc
tagged at the amino terminus and hemagglutinin (HA)
tagged at the carboxyl terminus]. Viruses were applied to
cells along with 8mg/ml polybrene and cells were
centrifuged at 300g for 1h. The mRNA was isolated
from infected cells after 24h.
4484 Nucleic Acids Research, 2012,Vol.40, No. 10Reporter assays
PCR ampliﬁcation was performed to obtain fragments of
genomic DNA from DDR gene promoters. These frag-
ments were cloned into the luciferase reporter vector,
pGL3 (Promega). Luciferase assays were performed as
described previously (36).
Measurement of mRNA levels
RNA was extracted using TRIzol reagent (Invitrogen),
and cDNA was prepared using Superscript II RNase
H-reverse transcriptase kit (Invitrogen) following the
manufacturer’s instructions. Real time PCR was per-
formed on a Rotor-Gene instrument (Corbett Life
Science) using the QuantiTect SYBR Green PCR Kit
(Qiagen) and speciﬁc primer pairs for each gene
(Supplementary Table S1).
Clonogenic survival assays
The siRNA-treated MCF7 cells or MEF Cux1
Z/Z and
Cux1 wild-type cells were exposed to either IR at doses
of 1, 2 and 4Gy, or to UV at doses of 2, 5 and 10J/m
2.
For MCF7, 500 cells were plated in 60-mm dishes in trip-
licate. For MEFs, 5000 cells were plated. After 10 days of
incubation, cells were washed with phosphate-buffered
saline (PBS), ﬁxed with 10% phosphate buffered
formalin for 10–20min then stained with 0.1% crystal
violet (Acros Organics) in 20% methanol for 5–10min.
The number of colonies with 50 cells or more was counted.
Immunoﬂuorescence
Cells were plated on glass coverslips and ﬁxed in 4%
paraformaldehyde. For g-H2AX staining, the cell
membrane was solubilized in PBS containing 5% FBS
and 0.5% Triton X-100. The samples were incubated for
1h in the solubilizing solution containing primary
antibodies for g-H2AX. Secondary detection was done
with Alexa Fluor 488-conjugated antibodies (Molecular
Probes) and cells were counterstained with
40,6-diamidino-2-phenylindole (Molecular Probes). Visua-
lization was done using an Axiovert 200M microscope
with an LSM 510 laser module (Zeiss). Images were
analyzed using ImageJ64 software.
For Rad51 staining, cells were solubilized in 0.5%
Igepal CA-630 and blocked in 10% FBS, 0.1% Igepal
for 1h prior to 3-h incubation with a primary antibody
against Rad51 in blocking solution. Secondary detection
and visualization was performed as indicated above.
Western blotting
Nuclear extracts were prepared according to the proced-
ure of Lee et al. (37) except that nuclei were obtained by
submitting cells to three freeze/thaw cycles in buffer A
(10mM HEPES, pH 7.9, 10mM KCl, 1.5mM MgCl2,
1mM dithiothreitol) along with protease inhibitor and
phosphatase inhibitor tablets (Roche). Sodium dodecyl
sulfate–polyacrylamide gel electrophoresis (SDS–PAGE)
was performed, and after electrophoretic transfer to
polyvinylidene diﬂuoride, membranes were washed in
Tris-buffered saline–0.1% Tween 20 (TBS 0.1%T) and
blocked in TBS 0.1%T containing 5% milk and 2%
Bovine Serum Albumin. Membranes were probed with
antibodies in TBS 0.1%T at room temperature for 1.5h
for primary antibodies and for 45min for secondary
antibodies.
Antibodies
The following antibodies were used for western blotting:
anti-Actin (human and mouse), anti-ATR (human) from
Santa Cruz Biotechnology (sc-1616, sc-1887); anti-ATM
and anti-ATR (mouse) from AbCam (Ab78, Ab2905);
anti-ATM (human), anti-p53 from Calbiochem (PC116,
OP43); anti-p-ATM from Rockland (200-301-400);
Anti-Chk1, p-Chk1, Chk2, p-Chk2 from Cell Signaling
(2345, 2344S, 2662, 2661L); anti-53bp1 from BD
Biosciences (612522).
For immunoﬂuorescence: anti-g-H2AX from Cell
Signaling (2577); anti-Rad51 from Santa-Cruz (sc-8349).
For ﬂow cytometry experiments: 488-conjugated anti-
BrdU from Molecular Probes (A21303)
G1/S and G2/M checkpoint assay
Cells were trypsinized, ﬁxed in 75% ethyl alcohol and
stored at  20 C overnight. A quantity of 50ml of FBS
was then added to each sample. The cells were centrifuged,
washed in PBS and resuspended in 300ml of PBS contain-
ing 200mg/ml of RNase (Sigma) and 5mg/ml of propidium
iodide (Sigma). Samples were incubated for 15min
at 37 C and analyzed using a FACScan (Becton
Dickinson), with doublet discrimination to gate single
cells. Cell cycle proﬁles were obtained with FlowJo
software (Tree Star Software).
BrdU incorporation assay
At the indicated times, 5-Bromo-20-deoxyuridine (BrdU)
was added to the culture media at 100mM and incubated
for 1h. Cells were then trypsinized and ﬁxed in 4%
paraformaldehyde. The cell membrane was solubilized in
PBS containing 5% FBS and 0.5% Triton X-100. The
samples were incubated for 1h in the solubilizing
solution containing a ﬂuorescent BrdU antibody. The
cells were then centrifuged, washed in PBS, stained with
propidium iodide and analyzed as for the G1/S and G2/M
checkpoint assays, except that BrdU incorporation in S
phase cells was scored.
Single cell electrophoresis
To measure strand breaks, single cell electrophoresis
(comet assays) using alkaline lysis were carried out as
described in (38). Comet tail moments were measured
using the CometScore software (TriTeck Corp).
Cytogenetic analyses
Karyotyping, metaphase chromosome counts and
breakage studies were carried out at the Quebec
Leukemia Cell Bank (http://www.bclq.org/en/index.html).
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CUX1 targets a signiﬁcant number of genes involved
in the DDR
Our laboratory previously carried out genome-wide
location analysis on a panel of eight cell lines using
promoter microarrays to identify direct transcriptional
targets of p110 CUX1 (5). Functional grouping of
CUX1 targets using the DAVID software (39) revealed
cell cycle checkpoint genes to be among the most
enriched categories (Table 1). We used multiple experi-
mental approaches to investigate the role of CUX1 in
transcriptional regulation of 18 putative targets known
to be involved in DDR checkpoint signaling (Table 2).
First, chromatin immunoprecipitation followed by
Real-Time PCR (ChIP–qPCR) was employed to
measure CUX1 recruitment to each promoter (Table 2,
column 2). Second, mRNA expression of DDR target
genes was quantiﬁed in the context of CUX1 deﬁciency,
either using siRNA-mediated knockdown (Figure 1A) or
by comparing MEF cells from wild-type versus Cux1
Z/Z
mutant mice (Figure 1B) (7). A signiﬁcant transcriptional
effect was observed in both assays for 14 out of 18 genes
and in one assay for the remaining 4 genes. All genes
manifested decreased expression upon CUX1 knockdown,
with the exception of CDKN1A (a.k.a. p21), which was
up-regulated (Figure 1 and Table 2, columns 3–6).
Third, Hs578t cells were infected with a retroviral vector
expressing p110 CUX1 and the expression of target genes
measured 24h later. All genes displayed increased mRNA
levels, with the exception of CDKN1A, which was
down-regulated (Figure 1C and Table 2, column 7).
Fourth, we cloned the proximal promoter region of
seven target genes into a reporter construct to verify
whether these genomic sequences were sufﬁcient to
confer regulation by p110 CUX1 (Figure 1D and
Table 2, column 6). Except for CDKN1A which was re-
pressed, all tested genes were activated by p110 CUX1.
The regulatory effects of CUX1 on CDKN1A expression
observed using these three assays are in agreement with
previous studies reporting the role of CUX1 as a tran-
scriptional repressor of this gene (4,22,41–45).
Altogether, the above data conclusively show that
CUX1 binds to the promoters of many DDR genes and
regulates their expression.
DDR signaling is reduced in CUX1-deﬁcient cells
The decrease in DDR gene expression upon CUX1
knockdown suggests that this transcription factor contrib-
utes to the maintenance of a transcriptional program
required for cellular responses to mutagenic insult.
Among CUX1 targets (Table 2) are critical kinases
involved in the transmission of DNA damage signals to
downstream effectors, speciﬁcally ATM/Chk2 and ATR/
Table 1. Over-represented biological functions of CUX1 targets
Function Background
(%)
Targets
(%)
P-value
Mitotic cell cycle 2.6 4.9 2.12E-10
DNA replication and
chromosome cycle
1.5 3.0 3.46E-08
Cell cycle 5.6 8.3 4.18E-08
Cell proliferation 8.5 11.6 8.83E-08
M phase of mitotic cell cycle 1.0 2.3 9.66E-08
Mitosis 1.0 2.2 1.65E-07
M phase 1.3 2.6 3.57E-07
DNA replication 1.1 2.3 1.44E-06
Nuclear division 1.3 2.5 1.90E-06
S phase of mitotic cell cycle 1.2 2.3 2.24E-06
DNA metabolism 4.2 6.3 2.37E-06
Cell growth and/or maintenance 30.3 34.0 7.61E-05
Intracellular transport 4.5 6.1 0.00044
Nucleosome assembly 0.5 1.1 0.00049
Protein metabolism 19.9 22.6 0.00061
DNA-dependent DNA replication 0.6 1.2 0.00074
Cell cycle checkpoint 0.3 0.7 0.00079
Regulation of cell cycle 3.1 4.3 0.00090
Small GTPase mediated
signal transduction
1.9 2.8 0.00110
Protein folding 1.0 1.7 0.00186
A single list of putative targets of CUX1 was compiled from eight
individual ChIP–chip experiments from cell lines overexpressing p110
CUX1. Genes that were bound by CUX1 (Targets) were compared
with all genes present on the microarray (Background) by using a
web-based functional annotation tool, DAVID. Overrepresentation of
a function depends on the increase in the proportion of genes involved
in a given function between CUX1 targets and the background. The
P-value is determined using an improved Fisher’s exact test from the
DAVID software (40). The top 20 signiﬁcantly over-represented func-
tions are shown.
Table 2. Transcriptional targets of CUX1 involved in DDR
Symbol ChIP–
qPCR
siRNA MEF
CUX1
z/z
Overexpression Reporter
ATM 5.1 0.74* 0.61*** 2.9**
ATR 3.9 0.56*** 0.56*** 2.3*** 4.7*
BRCA1 2.4 0.40** 0.63*** 4.5***
CCNG1 4.9 0.71* 0.68*** 3.5*** 2.6*
CDKN1A 2.7 1.32*** 1.32* 0.5* 0.2***
CHK1 3.2 0.58*** 0.57*** 4.4*** 3.7**
CHK2 2.1 0.68** 0.79*** 2.6***
FANCD2 2 0.76** 0.71*** 2.6***
MDM2 5.3 0.93 0.57*** 3*** 1.7**
NBS1 2.2 0.56*** 0.97 2.6**
RAD17 2.8 0.50*** 1.10 2.2**
RPA1 2.2 0.89 0.65*** 3***
RPA2 3.7 0.61*** 0.87* 5.5***
RPA3 19.4 0.65*** 0.86** 3.2*** 5.7*
SMC1L1 3.1 0.82* 0.57*** 2***
TOPBP1 3.3 0.52*** 0.45*** 3.6**
TP53 6 0.67* 0.72* 2.4* 9**
TP53BP1 2.5 0.65* 0.82* 3.3***
GAPDH 0.91 1.06 0.94 1.02
ACTB 1.22 1.00 1.01 1.01
UBC 0.84 0.96 1.08 1.05
Table shows the validation of regulation of DDR genes by CUX1.
Column 2 shows enrichment of CUX1 at each gene’s promoter.
Column 3 shows mRNA levels of DDR genes following siRNA
knockdown. Column 4 shows mRNA levels in Cux1
Z/Z MEFs
relative to wild-type littermates. Column 5 shows mRNA levels follow-
ing overexpression of p110 CUX1 by retroviral infection. All mRNA
levels are shown normalized to HPRT1; GAPDH, Actin Beta (ACTB)
and Ubiquitin C (UBC) are shown as additional housekeeping genes
that are unaffected by CUX1 levels. Column 6 shows level of activation
of reporter constructs by p110 CUX1.
*P<0.05, **P<0.01, ***P<0.001.
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(e.g. IR-induced) and replication stress (e.g. UV-induced),
respectively. We therefore investigated whether DDR sig-
naling through these kinases is impaired in the absence of
CUX1.
Immunoblotting assays were initially performed to in-
vestigate the expression and phosphorylation status of
checkpoint kinases following DNA damage. Transfection
of MCF7 cells with CUX1-speciﬁc siRNA greatly reduced
CUX1 expression (Figure 2A, lanes 1 and 3). IR treatment
per se did not modulate CUX1 expression in MCF7 cells
(Figure 2A, compare lanes 1 and 2, and lanes 3 and 4).
Although Chk1 and Chk2 mRNA levels were decreased in
CUX1-deﬁcient cells (Figure 1A and Table 2), protein
Figure 1. Transcriptional regulation of DDR genes by CUX1. (A) MCF7 cells were transfected with CUX1-speciﬁc siRNA. Top panel: mRNA and
protein levels of CUX1 are shown following knockdown. Bottom panel: mRNA levels of DDR gene targets are shown. All mRNA levels are
normalized to Hypoxanthine-guanine phosphoribosyltransferase (HPRT). The values are the mean of three measurements and error bars represent
standard deviation. *P<0.05 on a student’s t-test. (B) Mouse embryonic ﬁbroblasts (MEFs) were obtained from Cux1 knockout embryos (cux1
Z/Z)
and wild-type littermates. Levels of CUX1 and DDR gene targets are shown as in A; *in top panel corresponds to non-speciﬁc band recognized by
CUX1 antibody. (C) Hs578T cells were infected with a retrovirus expressing p110 CUX1 or with the empty vector. RNA was prepared 24h
post-infection and levels of DDR target genes was measured by real-time PCR and normalized to HPRT. The values are the mean of three
measurements and error bars represent standard deviation. (D) The promoter regions of target genes were cloned into a luciferase reporter
plasmid. Hs578T cells were transfected with each reporter plasmid along with a vector expressing p110 CUX1 or with an empty vector. The
values are the mean of three measurements and error bars represent standard deviation.
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that translational or post-translational mechanisms play
an important role in regulating Chk1 and Chk2 protein
levels. On the other hand, we noted a decrease in
steady-state levels of the ATR and ATM kinases, and of
the adaptor protein 53BP1 which is critical for
ATM-mediated Chk2 activation in response to DSBs
(46) (Figure 2B and C, compare lanes 1 and 2 with 3
and 4). Using phospho-speciﬁc antibodies, we also
detected a strong reduction in phosphorylation of Chk1
Ser317 following UV-irradiation (Figure 2C, compare
lanes 2 and 4) and an even more striking decrease in phos-
phorylation of Chk2 Thr68 and ATM Ser1981 after
IR (Figure 2B, compare lanes 2 and 4). These results
indicate that both ATM and ATR exhibit reduced
activity after DNA damage in CUX1-deﬁcient cells. In
addition, p53 accumulation following IR exposure was
reduced in siRNA treated cells (Figure 2D, compare
lanes 2 and 4), possibly due to impaired ATM/Chk2 sig-
naling (47). Importantly, a decrease in ATM and ATR
steady-state levels was also observed in Cux1
Z/Z MEFs
(Figure 2E).
Immunoﬂuorescence microscopy was next employed to
evaluate phosphorylation of H2AX (g-H2AX), well
characterized as a very early event mediated by ATR
and ATM following exposure to UV and IR, respectively
(48). Consistent with previous ﬁndings, diffuse g-H2AX
nuclear staining was evident following treatment with
20J/m
2 of UV, whereas distinct foci were discernable in
cells treated with 10Gy of IR (Figure 3) (35). However, in
both MEFs and MCF7, knockdown of CUX1 caused a
decrease in the proportion of cells showing a positive
g-H2AX signal after UV-irradiation and in the number
of g-H2AX foci per cell after IR (Figure 3A and B).
The above results, taken together, indicate that CUX1
is required for optimal signal transduction downstream of
ATM and ATR in response to DNA damage.
CUX1-deﬁcient cells are sensitive to the cytotoxic effects
of diverse-acting DNA damaging agents
The above results suggest that knockdown of CUX1
would render cells more sensitive to the cytotoxic effects
of diverse genotoxic agents. We tested this using either
(i) siRNA-mediated knockdown of CUX1 in MCF-7 or
(ii) MEFs from wild-type or Cux1
Z/Z mutant mice, fol-
lowing exposure to IR or UV. In response to either agent,
in both experimental systems, CUX1-deﬁcient cells
exhibited signiﬁcantly decreased clonogenic survival
(Figure 4). The well-established role of CUX1 in cell pro-
liferation (20) cannot account for these differences since
colony forming ability in mutagen-treated cells is
calculated relative to undamaged cells. Furthermore, in
the absence of DNA damage, there was no disparity in
the absolute number of colonies between cells expressing
more versus less CUX1 (Supplementary Figure S1). We
conclude that the ability of cells to survive in the face of
genotoxic insult is compromised when CUX1 is either
inactivated or its expression is reduced.
Figure 2. Western blotting of DDR signaling kinases, partners and
substrates. (A–D) MCF7 Cells were transfected with CUX1-speciﬁc
siRNA. Nuclear extract were prepared and analyzed by immunoblot-
ting. (A) Cells were exposed to 10Gy of IR, incubated for 1h prior to
harvest and the extracts were immunoblotted for CUX1 to assess
knockdown. (B) Cells were treated as in (A) and immunoblotted for
ATM, p-ATM, 53BP1, Chk2 and p-Chk2. Actin was used to control
for equal loading. (C) Cells were exposed to 20 Js of UV, incubated for
2h prior to harvest and the extracts were immunoblotted for ATR,
Chk1 and p-Chk1. (D) Cells were exposed to 10Gy of IR, incubated
for 6h prior to harvest and the extracts were immunoblotted for p53
and CUX1. Actin was used to control for equal loading. (E) Nuclear
extracts from Cux1
Z/Z and wild-type MEFs were immunoblotted for
ATM or ATR following exposure to 10Gy of IR (left panel) or 20
Js of UV (right panel), respectively.
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In light of the attenuated ATM/ATR signaling response
and reduced viability of CUX1-deﬁcient cells during
genotoxic stress, the capacity of such cells to trigger cell
cycle checkpoints was investigated. We ﬁrst evaluated the
G1/S checkpoint using ﬂow cytometry to quantify the pro-
portion of cells remaining in G1 24h post-treatment with
IR or UV. The assay was performed on cells synchronized
by treatment with the mitotic inhibitor nocodazole prior
to irradiation, to exclude the possibility of G1 re-entry of
cells that were in G2/M at the time of irradiation.
Treatment of MCF7 cells with 10Gy IR led to a 21.6%
increase in the fraction of cells remaining in G1
(Figure 5A, left panels, from 10.9 to 32.5% G1,
nocodazole versus nocodazole+IR). This increase
reﬂects cells that were prevented from progressing into S
phase as a result of the ATM-mediated G1/S checkpoint.
Signiﬁcantly, siRNA-mediated knockdown of CUX1
attenuated the increase in G1 to 13.9% (Figure 5A, right
panels, from 11.8 to 25.7% G1, nocodazole versus
nocodazole+IR). Similarly, following treatment with
UV, the increase in the G1 fraction was signiﬁcantly
reduced in siRNA-treated MCF7 cells as compared with
the control cells (Figure 5A, nocodazole versus
nocodazole+UV, results summarized in Figure 5B).
A similar trend was observed when the efﬁciency of the
G1/S checkpoint was compared between wild-type and
Cux1
Z/Z MEF cells following exposure to either IR or
UV (Figure 5C). The above data indicate that RNAi
knockdown or genetic inactivation of CUX1 compromises
the G1/S checkpoint in cells afﬂicted with either DSBs or
increased replication stress.
The capacity of cells to abrogate DNA replication after
irradiation, as controlled by the S phase checkpoint, was
also assessed in CUX1 knockdown cells. To this end, we
measured incorporation of the deoxyuridine analog
bromodeoxyuridine (BrdU) in wild-type versus Cux1
Z/Z
MEFs. While both cell types showed a reduction in
BrdU incorporation following exposure to 10Gy of IR,
wild-type MEFs showed a more rapid and pronounced
decrease in the proportion of cells actively synthesizing
DNA following irradiation (Figure 5D).
Finally, G2/M arrest was evaluated in wild-type versus
Cux1
Z/Z MEFs, and in siRNA-treated MCF7 cells. The
increase in cellular G2 content was measured by ﬂow
cytometry 24h after exposure to IR. All irradiated cells
exhibited an increase in G2 content, although not to the
same extent, as illustrated by wild-type versus Cux1
Z/Z
MEFs (Figure 6A). While the G2 content of wild-type
MEFs increased by 5.2, 12.9 and 19.9% after exposure
to 10Gy, 15Gy and 20Gy, respectively, the G2 content
Figure 3. g-H2AX staining in cells after DNA damage. (A) MCF7 cells were transfected with CUX1-speciﬁc siRNA. Cells were ﬁxed and stained by
immunoﬂuorescence for g-H2AX. The proportion of g-H2AX positive cells was counted after treatment with UV. For cells treated with IR, the
number of g-H2AX foci per nuclei was counted. Representative images from experiments at 4h (UV) and 1h (IR) are shown next to each graph.
*P<0.05, **P<0.01, ***P<0.001; Fisher’s exact test for UV treatment or a student’s t-test for IR treatment. (B) MEF cells from Cux1
Z/Z
knockout embryos and wild-type littermates were exposed to DNA damage. Cells were treated and counted as in (A). Representative images
from experiments at 4h (UV) and 1h (IR) are shown next to each graph.
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z/z increased by only 0.3, 4.6 and
7.8% under the same conditions (Figure 6B). G2/M
arrest was also signiﬁcantly reduced in siRNA-
treated MCF7 cells, although to a less striking extent
(Figure 6C).
Taken together, these results indicate that CUX1 is
required for cells to mount a complete DNA
damage-induced cell cycle checkpoint response, which is
fully consistent with the role of this transcription factor in
ATM/ATR regulation documented herein.
CUX1 knockdown causes a decrease in Rad51 focus
formation and a delay in the repair of DNA strand breaks
Rad51 focus formation, a well characterized marker of
homologous recombination (49), was measured using im-
munoﬂuorescence. Treatment of MCF7 cells with CUX1
siRNA led to a marked decrease in the proportion of cells
displaying ﬁve or more Rad51 foci after IR (Figure 7A).
Similarly, Cux1
Z/Z MEFs displayed a strong reduction in
cells displaying Rad51 foci as compared with wild-type
counterparts (Figure 7B). These results indicate that
CUX1 is required for efﬁcient DNA double strand-break
repair by homologous recombination.
Using the single cell gel electrophoresis assay,
commonly known as the comet assay, we measured the
disappearance of DNA breaks following exposure to IR,
UV and H2O2 in MCF7 treated with CUX1 siRNA and in
Cux1
Z/Z MEFs. Judging from the lengths of comet tails,
DNA breaks persisted signiﬁcantly longer in CUX1-
defective cells (Figure 7C and D). Also, Cux1
Z/Z MEFs
cultured in either a 3 or 20% O2 environment with no
additional treatment displayed more damage than the
wild-type counterparts, suggesting a higher sensitivity to
endogenous DNA damaging agents, e.g. reactive oxygen
species produced during oxidative respiration (Figure 7D,
rightmost panel)
Genomic instability in CUX1
z/z MEF cells
Karyotyping analysis was performed on MEFs derived
from Cux1
Z/Z mutant mice and wild-type littermates.
Chromosome counting revealed a greater proportion of
tetraploid or near tetraploid cells in CUX1-deﬁcient cells
compared with wild-type cells (Figure 8A). In addition,
the number of chromosome breaks, as measured following
Giemsa staining, was signiﬁcantly increased in CUX1-
deﬁcient cells (Figure 8B). The above results indicate
that CUX1-deﬁcient MEFs display increased genomic
instability.
DISCUSSION
The present study details the signiﬁcant role played by
CUX1 transcription factor in the cellular response to
genotoxic stress. Speciﬁcally, in the absence of exogenous
DNA damage, CUX1 transcriptionally up-regulates
various DDR genes including the ones encoding the
critical signaling kinases ATR and ATM. CUX1 similarly
stimulates the expression of (i) DNA damage sensors such
as NBS1, TopBP1 and RPA, that directly participate in
activation of these kinases (29,30,50) and (ii) of the
adaptor protein 53BP1 that couples ATM to Chk2 in
promoting phosphorylation of the latter (46). It should
be noted that relatively modest reductions in steady-state
levels of the aforementioned DDR proteins were observed
following either partial or complete abrogation of CUX1
in unstressed cells. However, after exposure to DNA
damaging agents, the effects of CUX1 depletion on acti-
vation of, and signaling through, both ATM and ATR
were much more striking. In addition, hallmark ATM/
ATR-regulated protective functions including cell cycle
checkpoints, survival, homologous recombination and
Figure 4. Effect of CUX1 knockdown on survival after DNA damage.
(A) MCF7 cells were transfected with CUX1-speciﬁc siRNA prior to
exposure to DNA damage. In total, 500 cells were plated in triplicate
and incubated for 10 days. Clones were ﬁxed, stained and counted and
the cloning efﬁciency of unexposed cells was set to 1. *P<0.05,
**P<0.01, ***P<0.001; Student’s t-test. (B) MEF cells from
Cux1
Z/Z knockout embryos and wild-type littermates were exposed to
DNA damage. 5000 cells were plated in triplicate and incubated for 10
days. Clones were ﬁxed, stained and counted and cloning efﬁciency of
unexposed cells was set to 1. (C) Representative images from experi-
ments with 1Gy IR in MEF cells (left) and 5J UV in MCF7 cells
(right).
4490 Nucleic Acids Research, 2012,Vol.40, No. 10Figure 5. Effect of CUX1 knockdown on G1/S and S phase arrest following damage. (A) MCF7 cells were transfected with CUX1-speciﬁc siRNA
and exposed to either 1mm Nocodazole, Nocodazole+10Gy of IR or Nocodazole+20 Js of UV. Cells were ﬁxed with ethanol 24h after exposure,
stained with Propidium Iodine (PI) and analyzed for cell cycle distribution by ﬂow cytometry. (B) A histogram of the increase in G1 content after IR
and UV in MCF7 cells. *P<0.05, **P<0.01, ***P<0.001; Student’s t-test. (C) A histogram of the increase in G1 content after IR and UV in
Cux1
Z/Z and Cux1 wt MEF cells treated and analyzed as in A. (D) Cux1
Z/Z and Cux1 wild-type MEF cells were exposed to 10Gy IR. 1 to 4 hours
post exposure, the cells were labeled with BrdU for 1h before ﬁxation with 4% Paraformaldehyde. BrdU incorporation was measured by ﬂow
cytometry.
Figure 6. Effect of CUX1 knockdown on G2/M arrest following IR. (A) Cux1
Z/Z and Cux1 wild-type MEF cells were exposed to 10Gy IR. Cells
were ﬁxed with ethanol 24h after exposure, stained with Propidium Iodide (PI) and analyzed for cell cycle distribution by ﬂow cytometry.
(B) A histogram of the increase in G2 content after IR in MEF cells. *P<0.05, **P<0.01, ***P<0.001; Student’s t-test. (C) A histogram of
the increase in G2 content after IR in MCF7 cells treated with either CUX1 siRNA or scrambled siRNA.
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impacted following mutagenic insult. This presumably
reﬂects the cooperative effects of CUX1-regulated DDR
proteins in triggering a robust ATM/ATR-mediated
DDR.
The eukaryotic DDR is classically perceived as being
triggered and sustained through post-translational
modiﬁcation of effector proteins imposed after the appli-
cation of genotoxic stress. However our results provide
compelling evidence that prior to sustaining DNA
damage, adequate basal DDR protein levels depend on
CUX1 transcriptional regulation and moreover, must be
in place such that the cells can respond efﬁciently to
mutagenic insult. This function of CUX1 (and quite
possibly of other transcription factors; see below), can
be distinguished from other, purely DNA damage-
inducible mechanisms of DDR gene activation, e.g. the
SOS response in bacteria (51–54) and yeast (55), or the
p53 tumor suppressor pathway in mammalian cells (56).
With this in mind, we speculate that the CUX1-mediated
transcriptional response revealed here may be important
for full protection against not only exogenous DNA
damage, but also highly-genotoxic DNA lesions of
endogenous origin such as oxidized bases and strand
breaks generated by cellular free radicals. This notion is
supported by the comparative analysis of Cux1
Z/Z and
wild-type MEFs showing a higher number of strand
breaks, a greater proportion of tetraploid or near
Figure 7. Effect of CUX1 knockdown on Rad51 focus formation and DNA break repair. (A) MCF7 cells were transfected with CUX1-speciﬁc
siRNA before exposure to 5Gy of IR. Cells were ﬁxed 1h after exposure and stained by immunoﬂuorescence for Rad51 foci. The proportion of cells
displaying ﬁve or more foci is shown. Non-irradiated cells are shown as controls. ***P<0.001; Student’s t-test. (B) Cux1
Z/Z and wild-type MEFs
were irradiated or mock-irradiated with 5Gy of IR. Cells were ﬁxed 1h later and stained by immunoﬂuorescence for Rad51 foci. The proportion of
cells displaying ﬁve or more foci is shown. (C) MCF7 cells were transfected with CUX1-speciﬁc siRNA and then exposed to 2Gy IR, 5J UV or
10mm H2O2 for 30min. At the indicated times, cells were collected and strand breaks quantiﬁed by Alkaline Single Cell Gel Electrophoresis (Comet
Assay). Comet tail moments were scored for at least 30 cells per conditions. Error bars represent standard error. *P<0.05, **P<0.01, ***P<0.001;
Student’s t-test. (D) Cux1
Z/Z and wild-type MEFs were exposed to IR, UV or H2O2. and DNA breaks were quantiﬁed as in (C). In addition, comet
tail moments were measured in MEFs maintained at 3 and 20% oxygen with no further treatment.
4492 Nucleic Acids Research, 2012,Vol.40, No. 10tetraploid cells and an increased number of chromosome
breaks in CUX1-deﬁcient MEFs (Figures 7D, 8A and B).
Results from this and other studies reveal a regulatory
loop involving CUX1 and key checkpoint kinases. While
we have identiﬁed CUX1 as an activator of constitutive
DDR gene expression, it should be emphasized that this
transcription factor itself was shown to be the target of
post-translational modiﬁcation following DNA damage.
Speciﬁcally, CUX1-derived peptides were identiﬁed in
two phosphoproteomic studies aimed at identifying
proteins phosphorylated after UV or IR (33,57). In
total, ﬁve phosphorylation sites were identiﬁed at pos-
itions 322, 734, 1233, 1312 and 1357. Since none of these
sites map within one of the four DNA binding domains of
CUX1 (CR1, CR2, CR3 and the Cut homeodomain),
their phosphorylation would not be expected to inhibit
DNA binding. Indeed, CUX1 DNA binding activity is
not diminished after DNA damage (Supplementary
Figure S2A, B and D), although the manner in which
CUX1 regulates transcription may certainly be altered.
For example, in agreement with earlier studies from
several groups (4,22,41–45), in unstressed cells we
observed that CUX1 represses CDKN1A which encodes
the p21 cyclin-dependent kinase inhibitor (Figure 1 and
Table 2). On the other hand, results using CUX1-deﬁcient
cells indicated that CUX1 is required for optimal
up-regulation of CDKN1A following DNA damage
(Supplementary Figure S2E). We speculate that phosphor-
ylation of CUX1 by checkpoint kinases during periods of
genotoxic stress affects its interactions with co-repressors
and co-activators, or imparts conformational changes that
alter its regulatory properties. The role of CUX1 in the
transcriptional program taking place after DNA damage,
and the identiﬁcation of kinases that phosphorylate this
transcription factor during genotoxic stress, will be
addressed in future studies.
Although a multitude of previous investigations have
sought to identify transcription factors that are regulated
downstream of DDR signal transduction pathways, only a
few attempted to reveal such transcription factors whose
activity is required prior to the application of genotoxic
stress: (i) expression proﬁling studies clearly showed a
role for E2F family members in the regulation of DNA
repair genes involved in homologous recombination, non-
homologous end-joining and base excision repair (58–60).
Subsequent chromatin immunoprecipitation studies con-
ﬁrmed that E2F transcription factors directly bind the
promoters of DDR genes in the absence of DNA
damage (59); moreover steady-state changes in the expres-
sion of DDR genes in Rb-deﬁcient cells was documented
(61,62), (ii) Stat3
 /  MEF cells were shown to exhibit a
weaker response and decreased survival following irradi-
ation and evidence from reporter assays suggested that
MDC1, the gene encoding mediator of DNA damage
checkpoint 1, is regulated by STAT3 (63), (iii) NFkB
was shown to bind to the promoter of ATM and to be
required for optimal expression of this kinase in T cells
(64), (iv) the FoxM1 transcription factor regulates baseline
levels of p21 and Chk1, and its overexpression is
associated with enhanced checkpoint activity (65).
Although limited in number, the above studies suggest
that preparing cells to cope with DNA damage constitutes
a critical function of various transcription factors also
known to play roles in cell cycle. Consistent with such a
notion, we have shown that CUX1, in addition to
regulating cell cycle progression and DNA replication in
unstressed cells, also contributes to the maintenance of
genomic integrity by ensuring that key players in the
DDR are present in stoichiometric amounts prior to
DNA damage.
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